AstraZeneca LP v. Watson Laboratories Inc

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Richard G. Andrews · 4,097 cases in index

Docket number

1:16-cv-00338

Cause

35:0145
35 U.S.C. § 145

Nature of suit

830 Patent
Infringement of a patented invention.

Jurisdiction

Federal Question

Jury demand

None

Date filed

05/09/2016

Date terminated

03/14/2018

11,768 Patent cases in this court are indexed here.

Parties

• plaintiff · Astrazeneca LP Pharmaceuticals & Biotechnology · 10349 cases
• defendant · Watson Laboratories Inc · 99 cases

Part of a Larger Litigation Pattern

This is one of 100 Patent cases in our index naming Watson Laboratories Inc — a possible mass-tort or coordinated-litigation cluster.

• Merck Sharp & Dohme Corp v. Watson Laboratories, Inc
  District Court, D. DelawareFiled 02/13/2019
• Alcon Research, Ltd v. Watson Laboratories, Inc
  District Court, D. DelawareFiled 03/10/2017
• Amgen Inc v. Watson Laboratories, Inc
  District Court, D. DelawareFiled 09/22/2016
• Alcon Research, Ltd v. Watson Laboratories, Inc
  District Court, D. DelawareFiled 04/07/2016
• Senju Pharmaceutical Co., Ltd v. Watson Laboratories, Inc
  District Court, D. New JerseyFiled 03/18/2016
• Jazz Pharmaceuticals, Inc v. Watson Laboratories, Inc
  District Court, D. New JerseyFiled 03/17/2016

About Patent Lawsuits

Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

Frequently Asked Questions

What is AstraZeneca LP v. Watson Laboratories Inc?

AstraZeneca LP v. Watson Laboratories Inc is a federal patent lawsuit filed on 05/09/2016 in the District Court, D. Delaware. The case was terminated on 03/14/2018. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What type of case is this?

It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:16-cv-00338.

When was the case filed?

AstraZeneca LP v. Watson Laboratories Inc was filed on 05/09/2016. It was terminated on 03/14/2018.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 145.